
CENTURY THERAPEUTICS INC
IPSC · NASDAQ
Updated at 2026-10-17 22:08:12
- Today's High
- $1.55
- Today’s Low
- $1.37
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.50
- Previous Close
- $1.37
- Volume
- 722.5K
- Market Cap
- $248.07M
- P/E Ratio
- --
- EPS
- $-0.89
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 25 NORTH 38TH STREET, PHILADELPHIA, PA, UNITED STATES, 19104
- Country
- US
- Listing Date
- 2021-06-17
- Fiscal Year End
- December
- Shares Outstanding
- 180.35M
- CIK
- 0001850119
- Website
- www.centurytx.com
Century Therapeutics Inc. (Ticker: IPSC) is a leading biotechnology company specializing in allogenic cell therapy, with a transformative approach to cancer treatment. Leveraging its pioneering induced pluripotent stem cell (iPSC) technology, Century is committed to developing innovative off-the-shelf therapeutics designed to improve patient outcomes and expand accessibility to care. With a diverse array of clinical-stage assets and strategic collaborations that enhance its market position, Century Therapeutics presents compelling investment opportunities in the burgeoning cell therapy landscape, positioning itself for significant growth within the biotech industry.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$36.52M
2026-03-31
$22.49M
2025-12-31
$20.65M
2025-09-30
$13.59M
Net Income
2026-06-30
-$34.55M
2026-03-31
-$21.64M
2025-12-31
-$19.17M
2025-09-30
-$34.42M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.17
2026-03-31
$-0.11
2025-12-31
$-0.25
2025-09-30
$-0.32
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$31.93M
2026-03-31
-$18.64M
2025-12-31
-$15.68M
2025-09-30
-$26.23M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
0.35%
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $36.52M | $22.49M | $20.65M | $13.59M |
| Net Income | -$34.55M | -$21.64M | -$19.17M | -$34.42M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.17 | $-0.11 | $-0.25 | $-0.32 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$31.93M | -$18.64M | -$15.68M | -$26.23M |
| Effective Tax Rate | -- | -- | 0.35% | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.